The pathogenesis of cholera and some wider implications.
D000086:Acetazolamide / Q000494:pharmacology; D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D002771:Cholera / Q000503:physiopathology*; D000242:Cyclic AMP / Q000502:physiology; D003967:Diarrhea / Q000209:etiology; D004285:Dogs; D004386:Duodenum / Q000378:metabolism; D004926:Escherichia coli / Q000472:pathogenicity; D004976:Ethacrynic Acid / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D005755:Gastrins / Q000097:blood; D006801:Humans; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism; D008954:Models, Biological; D010455:Peptides; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000378:metabolism; D014118:Toxins, Biological; D014462:Ultrafiltration; D015043:Zollinger-Ellison Syndrome / Q000150:complications
D005755:Gastrins; D010455:Peptides; D014118:Toxins, Biological; D000666:Amphotericin B; D012964:Sodium; D000242:Cyclic AMP; D004976:Ethacrynic Acid; D000086:Acetazolamide